OBJECTIVE: Few data are available regarding the long-term psychological impact of uninformative BRCA1/2 test results. This study examines change in distress from pretesting to 12-months post-disclosure, with medical, family history, and psychological variables, such as pretesting perceived risk of carrying a deleterious mutation prior to testing and primary and secondary appraisals, as predictors. METHODS: Two hundred and nine women with uninformative BRCA1/2 test results completed questionnaires at pretesting and 1-, 6-, and 12-month post-disclosure, including measures of anxiety and depression, cancer-specific and genetic testing distress. We used a mixed models approach to predict change in post-disclosure distress. RESULTS: Distress declined from pretesting to 1-month post-disclosure, but remained stable thereafter. Primary appraisals predicted all types of distress at 1-month post-disclosure. Primary and secondary appraisals predicted genetic testing distress at 1-month as well as change over time. Receiving a variant of uncertain clinical significance and entering testing with a high expectation for carrying a deleterious mutation predicted genetic testing distress that persisted through the year after testing. CONCLUSIONS: As a whole, women receiving uninformative BRCA1/2 test results are a resilient group. For some women, distress experienced in the month after testing does not dissipate. Variables, such as heightened pretesting perceived risk and cognitive appraisals, predict greater likelihood for sustained distress in this group and could be amenable to intervention.
OBJECTIVE: Few data are available regarding the long-term psychological impact of uninformative BRCA1/2 test results. This study examines change in distress from pretesting to 12-months post-disclosure, with medical, family history, and psychological variables, such as pretesting perceived risk of carrying a deleterious mutation prior to testing and primary and secondary appraisals, as predictors. METHODS: Two hundred and nine women with uninformative BRCA1/2 test results completed questionnaires at pretesting and 1-, 6-, and 12-month post-disclosure, including measures of anxiety and depression, cancer-specific and genetic testing distress. We used a mixed models approach to predict change in post-disclosure distress. RESULTS: Distress declined from pretesting to 1-month post-disclosure, but remained stable thereafter. Primary appraisals predicted all types of distress at 1-month post-disclosure. Primary and secondary appraisals predicted genetic testing distress at 1-month as well as change over time. Receiving a variant of uncertain clinical significance and entering testing with a high expectation for carrying a deleterious mutation predicted genetic testing distress that persisted through the year after testing. CONCLUSIONS: As a whole, women receiving uninformative BRCA1/2 test results are a resilient group. For some women, distress experienced in the month after testing does not dissipate. Variables, such as heightened pretesting perceived risk and cognitive appraisals, predict greater likelihood for sustained distress in this group and could be amenable to intervention.
Authors: Sandra van Dijk; Christi J van Asperen; Catharina E Jacobi; Geraldine R Vink; Aad Tibben; Martijn H Breuning; Wilma Otten Journal: Genet Test Date: 2004
Authors: Marc D Schwartz; Beth N Peshkin; Kenneth P Tercyak; Kathryn L Taylor; Heiddis Valdimarsdottir Journal: Health Psychol Date: 2005-07 Impact factor: 4.267
Authors: Suzanne C O'Neill; Tiffani DeMarco; Beth N Peshkin; Sarah Rogers; Jessica Rispoli; Karen Brown; Heiddis Valdimarsdottir; Marc D Schwartz Journal: Am J Med Genet C Semin Med Genet Date: 2006-11-15 Impact factor: 3.908
Authors: Sandra van Dijk; Wilma Otten; Daniëlle R M Timmermans; Christi J van Asperen; Hanne Meijers-Heijboer; Aad Tibben; Martijn H Breuning; Job Kievit Journal: Genet Med Date: 2005-04 Impact factor: 8.822
Authors: David Cella; Chanita Hughes; Amy Peterman; Chih-Hung Chang; Beth N Peshkin; Marc D Schwartz; Lari Wenzel; Amy Lemke; Alfred C Marcus; Caryn Lerman Journal: Health Psychol Date: 2002-11 Impact factor: 4.267
Authors: Mark Robson; Tiffany Svahn; Beryl McCormick; Patrick Borgen; Clifford A Hudis; Larry Norton; Kenneth Offit Journal: Cancer Date: 2005-01-01 Impact factor: 6.860
Authors: Bianca M Augusto; Paige Lake; Courtney L Scherr; Fergus J Couch; Noralane M Lindor; Susan T Vadaparampil Journal: J Community Genet Date: 2017-11-09
Authors: Suzanne C O'Neill; Darren Mays; Andrea Farkas Patenaude; Judy E Garber; Tiffani A DeMarco; Beth N Peshkin; Katherine A Schneider; Kenneth P Tercyak Journal: J Community Genet Date: 2014-08-07
Authors: Christine Rini; Suzanne C O'Neill; Heiddis Valdimarsdottir; Rachel E Goldsmith; Lina Jandorf; Karen Brown; Tiffani A DeMarco; Beth N Peshkin; Marc D Schwartz Journal: Health Psychol Date: 2009-09 Impact factor: 4.267